SMMT is trading at $15.37, up 6.9% versus the comparison close of $14.38 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this alert.
🟢 SMMT extends move to 6.9% up
Summit Therapeutics PLC
Related News
SMMT
Summit Starts Phase II/III Trial of Ivonescimab for First-Line Biliary Cancer
SMMT
🔴 Summit Therapeutics is trading 5% down in pre-market amid S&P 500 and Nasdaq declines
SMMT
Summit Therapeutics Proposes Doubling Authorized Shares to Support Preferred Conversion
SMMT
🟢 Summit Therapeutics is trading 5% up today amid broader market rebound
SMMT